The Use of Canagliflozin in Diabetes Mellitus Type 2 on Renal Outcome: A Systematic Review
Introduction: One of the leading causes of death in patients with diabetes mellitus is Diabetic Kidney Disease (DKD). Canagliflozin is one of the therapeutic options that can be used to mitigate the progression of DKD. However, the limited existing studies have left the data regarding the effects of...
Main Authors: | Vikri Haikal, Soebagijo Adi Soelistijo, Puspa, Jongky Hendro Prajitno |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculty of Medicine, Universitas Airlangga
2024-01-01
|
Series: | Current Internal Medicine Research and Practice Surabaya Journal |
Subjects: | |
Online Access: | https://e-journal.unair.ac.id/CIMRJ/article/view/50710 |
Similar Items
-
Effect of canagliflozin on the decline of estimated glomerular filtration rate in chronic kidney disease patients with type 2 diabetes mellitus: A multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group, phase III study in Japan
by: Takashi Wada, et al.
Published: (2022-12-01) -
Short-term outcomes of type 2 diabetes mellitus patients treated with canagliflozin in real-world setting
by: Manash P Baruah, et al.
Published: (2016-01-01) -
Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective properties in rats with experimental type 2 diabetes mellitus
by: A. V. Simanenkova, et al.
Published: (2021-07-01) -
Therapeutic Effects of Canagliflozin and Zinc Sulphate Alone and in Combination on Pancreatic Histology in Type-2 Diabetic Rat Model
by: Bushra Suhail, et al.
Published: (2020-12-01) -
Clinical Efficacy of Different Doses of Canagliflozin Combined with Metformin in the Treatment of Type 2 Diabetes Mellitus: a Meta-analysis
by: Yuying CHEN, Xiaodong LI, Yunzhao TANG, Daiqing LI
Published: (2022-05-01)